| Atopic 06 | Atopic Dermatitis |   | Ages 18-70 | Open for Enrollment | Clinical Trial investigating a new topical medication for adults with Atopic Dermatitis. The participation will be up to 20 weeks, including up to 4 weeks for screening, 8 weeks of double-blind treatment, 4 weeks of optional open-label treatment, and 4 weeks of safety follow up. Study medication is being developed for treatment of Atopic Dermatitis. | up to $350 |
Clinical Trial investigating a new topical medication for adults with Atopic Dermatitis. The participation will be up to 20 weeks, including up to 4 weeks for screening, 8 weeks of double-blind treatment, 4 weeks of optional open-label treatment, and 4 weeks of safety follow up. Study medication is being developed for treatment of Atopic Dermatitis.
